Lotus Pharmaceutical reports Aug revenue of NT$2.11B vs NT$1.16B
Lotus Pharmaceutical Co. Ltd. reported 2026 revenue of NT$2,107,202,000 versus NT$1,159,844,000 in 2025. It also reported Jan–Aug revenue of NT$22,051,986,000 versus NT$13,033,975,000.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Lotus Pharmaceutical Co. Ltd. reported 2026 revenue of NT$2,107,202,000 versus NT$1,159,844,000 in 2025. It also reported Jan–Aug revenue of NT$22,051,986,000 versus NT$13,033,975,000.